Table 3.
chemical analyte | n | % differenceb | 2008–2009 LSGM (95% CI) | 2011–2012 LSGM (95% CI) | p |
---|---|---|---|---|---|
PBDEs (ng/g lipid) | |||||
BDE-28 | 59 | −43 (−60, −17) | 2.15 (1.49, 3.09) | 1.23 (0.85, 1.78) | 0.004 |
BDE-47 | 59 | −44 (−61, −18) | 40.3 (27.9, 58.1) | 22.7 (15.7, 32.9) | 0.003 |
BDE-99 | 59 | −44 (−61, −17) | 9.69 (6.64,14.2) | 5.48 (3.74, 8.02) | 0.004 |
BDE-100 | 59 | −47 (−65, −19) | 10.0 (6.60,15.2) | 5.31 (3.48, 8.09) | 0.004 |
BDE-153 | 59 | −25 (−47, 6) | 23.0 (16.2, 32.5) | 17.2 (12.1, 24.4) | 0.10 |
ΣPBDEs | 59 | −39 (−56, −15) | 90.0 (64.7, 125.2) | 54.6 (39.2, 76.2) | 0.004 |
PCBs (ng/g lipid) | |||||
PCB-74 | 59 | −26 (−46, 1) | 1.26 (0.92, 1.72) | 0.93 (0.68, 1.27) | 0.06 |
PCB-118 | 59 | −10 (−34, 24) | 2.04 (1.49, 2.81) | 1.85 (1.34, 2.54) | 0.53 |
PCB-138 | 59 | −6 (−31, 29) | 2.96 (2.17, 4.05) | 2.79 (2.04, 3.82) | 0.70 |
PCB-153 | 59 | −9 (−36, 30) | 4.34 (3.05, 6.17) | 3.96 (2.78, 5.65) | 0.61 |
PCB-180 | 59 | −42 (−59, −18) | 3.83 (2.72, 5.38) | 2.23 (1.59, 3.15) | 0.003 |
ΣPCBs | 59 | −20 (−40, 7) | 15.1 (11.3, 20.1) | 12.0 (8.98, 16.1) | 0.13 |
OH-PBDEs (ng/mL) | |||||
5-OH-BDE47 | 58 | −83 (−92, −66) | 0.042 (0.020, 0.088) | 0.007 (0.003, 0.014) | <0.0001 |
6-OH-BDE47 | 58 | −84 (−91, −71) | 0.039 (0.022, 0.070) | 0.006 (0.004, 0.011) | <0.0001 |
ΣOH-PBDEs | 58 | −86 (−92, −75) | 0.099 (0.055, 0.179) | 0.014 (0.008, 0.025) | <0.0001 |
ΣOH-PCBs (ng/mL) | 58 | −8 (−41, 43) | 0.020 (0.013, 0.031) | 0.018 (0.012, 0.028) | 0.71 |
Chemical analyte concentrations were natural log-transformed in multivariate regression models.
Reference group is 2008−2009 cohort.
Abbreviations: CI = confidence intervals; LSGM = least-squares geometric mean.